Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Gut bacteria may help tame alcohol cravings, new study suggests

NCT ID NCT05830708

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study investigates whether a daily probiotic supplement containing Lactobacillus bacteria can help reduce alcohol cravings, withdrawal symptoms, and the severity of alcohol use disorder in adult men. Participants take either the probiotic or a placebo for 12 weeks, and researchers track changes in cravings, mood, and inflammation markers. The goal is to see if improving gut health can support recovery from alcohol dependence.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Lactobacillus sp. probiotic
What this could lead to
If effective, probiotics could offer a simple, low-cost way to help manage alcohol cravings and withdrawal, potentially improving treatment outcomes.
What could go wrong
This is a small, early-stage trial with only 58 participants, so results may not apply broadly. Probiotics may have no effect on alcohol use disorder symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

58 people

The number who actually took part.

Started

Jun 2022

Finished

Jun 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 55 years

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria (AUD patients): * Hospitalized patients diagnosed with untreated alcohol use disorder (confirmed by the diagnostic criteria of DSM-5). * Male, age 18 to 55 years old, Han nationality, junior high school education or above, right-handed. * Those with normal eyesight, including corrected vision(screened clinically). Exclusion Criteria (AUD patients): * The patient suffer from other mental illnesses (screen by DSM-V criteria). * The patient has allergy reaction to medications use for conventional treatment of alcohol use disorder. * The patient had a history of organic brain disease, a pacemaker, gastrointestinal surgery, or serious health problems. * The patient had a history of seizures. * The patient is complicated with severe physical disease. * Patient has other drug dependence (except for nicotine dependence). * The patient took drugs affecting intestinal flora 30 days before and during admission. * The patient has participated in any other alcohol-related studies or trials within the past 30 days. * Patients had use any prescription or over-the-counter drugs in the past 30 days that may affect mood or alcohol cravings. Inclusion Criteria (controls): * Male, age 18 to 55 years old, Han nationality, junior high school education or above, right-handed. * No history of psychoactive substance abuse, except tobacco (screen with urine dipstick test). * Those with normal eyesight, including corrected vision (screen clinically). * No alcoholic beverages in the last 2 weeks. * According to the WHO healthy alcohol consumption standard, the average intake of pure alcohol per week is less than 210 grams, or do not drink at all (screen clinically). Exclusion Criteria (controls): * Those who suffer from other mental illnesses (screen by DSM-V criteria). * Those who has history of organic brain disease, a pacemaker, gastrointestinal surgery, or serious health problems. * Those who has history of seizures. * Those complicated with severe physical disease. * Those with drug dependence, including alcohol dependence (exception for nicotine dependence). * Those who took drugs affecting intestinal flora 30 days before and during admission. * Those who has participated in any other alcohol-related studies or trials within the past 30 days. * Those who use any prescription or over-the-counter drugs in the past 30 days that may affect mood or alcohol cravings.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alcohol use disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Second Affiliated Hospital of Henan Medical University

    Xinxiang, Henan, 453000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.